Author/Authors :
Suzanne L Jacques، نويسنده , , I.Ahmad Mirza، نويسنده , , Linda Ejim، نويسنده , , Kalinka Koteva، نويسنده , , Donald W. Hughes، نويسنده , , Kirk Green، نويسنده , , Robert Kinach، نويسنده , , John F. Honek، نويسنده , , Hoi Kiong Lai، نويسنده , , Albert M Berghuis، نويسنده , , Gerard D Wright، نويسنده ,
Abstract :
The structure of the antifungal drug 5-hydroxy-4-oxonorvaline (HON) in complex with its target homoserine dehydrogenase (HSD) has been determined by X-ray diffraction to 2.6 Å resolution. HON shows potent in vitro and in vivo activity against various fungal pathogens despite its weak (2 mM) affinity for HSD in the steady state. The structure together with structure-activity relationship studies, mass spectrometry experiments, and spectroscopic data reveals that the molecular mechanism of antifungal action conferred by HON involves enzyme-dependent formation of a covalent adduct between C4 of the nicotinamide ring of NAD+ and C5 of HON. Furthermore, novel interactions are involved in stabilizing the (HON•NAD)-adduct, which are not observed in the enzymeʹs ternary complex structure. These findings clarify the apparent paradox of the potent antifungal actions of HON given its weak steady-state inhibition characteristics.